Logo image of ECN.CA

ECN CAPITAL CORP (ECN.CA) Stock Fundamental Analysis

Canada - TSX:ECN - CA26829L1076 - Common Stock

2.83 CAD
-0.06 (-2.08%)
Last: 10/17/2025, 7:00:00 PM
Fundamental Rating

5

ECN gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 29 industry peers in the Financial Services industry. While ECN seems to be doing ok healthwise, there are quite some concerns on its profitability. ECN is valued quite cheap, while showing a decent growth score. This is a good combination!


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year ECN was profitable.
In the past year ECN had a positive cash flow from operations.
In multiple years ECN reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: ECN reported negative operating cash flow in multiple years.
ECN.CA Yearly Net Income VS EBIT VS OCF VS FCFECN.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M

1.2 Ratios

ECN has a worse Return On Assets (0.01%) than 72.41% of its industry peers.
Looking at the Return On Equity, with a value of 0.03%, ECN is doing worse than 72.41% of the companies in the same industry.
ECN has a Return On Invested Capital (4.31%) which is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for ECN is below the industry average of 5.38%.
The last Return On Invested Capital (4.31%) for ECN is above the 3 year average (2.48%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 0.01%
ROE 0.03%
ROIC 4.31%
ROA(3y)-2.68%
ROA(5y)14.79%
ROE(3y)-16.1%
ROE(5y)77.16%
ROIC(3y)2.48%
ROIC(5y)1.63%
ECN.CA Yearly ROA, ROE, ROICECN.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200 300 400

1.3 Margins

With a Profit Margin value of 0.03%, ECN is not doing good in the industry: 72.41% of the companies in the same industry are doing better.
The Operating Margin of ECN (33.30%) is worse than 62.07% of its industry peers.
ECN's Operating Margin has improved in the last couple of years.
Industry RankSector Rank
OM 33.3%
PM (TTM) 0.03%
GM N/A
OM growth 3Y87.71%
OM growth 5Y15.55%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ECN.CA Yearly Profit, Operating, Gross MarginsECN.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 400 600

5

2. Health

2.1 Basic Checks

ECN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
ECN has more shares outstanding than it did 1 year ago.
The number of shares outstanding for ECN has been increased compared to 5 years ago.
ECN has a better debt/assets ratio than last year.
ECN.CA Yearly Shares OutstandingECN.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
ECN.CA Yearly Total Debt VS Total AssetsECN.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

ECN has an Altman-Z score of 0.05. This is a bad value and indicates that ECN is not financially healthy and even has some risk of bankruptcy.
ECN has a Altman-Z score of 0.05. This is amonst the worse of the industry: ECN underperforms 82.76% of its industry peers.
The Debt to FCF ratio of ECN is 3.27, which is a good value as it means it would take ECN, 3.27 years of fcf income to pay off all of its debts.
ECN has a better Debt to FCF ratio (3.27) than 89.66% of its industry peers.
ECN has a Debt/Equity ratio of 2.85. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of ECN (2.85) is worse than 68.97% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.85
Debt/FCF 3.27
Altman-Z 0.05
ROIC/WACC0.73
WACC5.92%
ECN.CA Yearly LT Debt VS Equity VS FCFECN.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B

2.3 Liquidity

ECN has a Current Ratio of 1.05. This is a normal value and indicates that ECN is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of ECN (1.05) is better than 82.76% of its industry peers.
ECN has a Quick Ratio of 1.05. This is a normal value and indicates that ECN is financially healthy and should not expect problems in meeting its short term obligations.
ECN has a better Quick ratio (1.05) than 82.76% of its industry peers.
Industry RankSector Rank
Current Ratio 1.05
Quick Ratio 1.05
ECN.CA Yearly Current Assets VS Current LiabilitesECN.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 750.00% over the past year.
ECN shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -20.31% yearly.
The Revenue has grown by 33.31% in the past year. This is a very strong growth!
The Revenue has been decreasing by -1.56% on average over the past years.
EPS 1Y (TTM)750%
EPS 3Y-34.48%
EPS 5Y-20.31%
EPS Q2Q%33.33%
Revenue 1Y (TTM)33.31%
Revenue growth 3Y21.98%
Revenue growth 5Y-1.56%
Sales Q2Q%3.83%

3.2 Future

Based on estimates for the next years, ECN will show a very strong growth in Earnings Per Share. The EPS will grow by 42.84% on average per year.
ECN is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 12.04% yearly.
EPS Next Y99.19%
EPS Next 2Y65.25%
EPS Next 3Y42.84%
EPS Next 5YN/A
Revenue Next Year11.92%
Revenue Next 2Y14.36%
Revenue Next 3Y12.04%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ECN.CA Yearly Revenue VS EstimatesECN.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
ECN.CA Yearly EPS VS EstimatesECN.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.1 0.2 0.3

8

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 15.72, which indicates a correct valuation of ECN.
ECN's Price/Earnings ratio is a bit cheaper when compared to the industry. ECN is cheaper than 68.97% of the companies in the same industry.
When comparing the Price/Earnings ratio of ECN to the average of the S&P500 Index (27.40), we can say ECN is valued slightly cheaper.
The Price/Forward Earnings ratio is 8.19, which indicates a very decent valuation of ECN.
93.10% of the companies in the same industry are more expensive than ECN, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.94, ECN is valued rather cheaply.
Industry RankSector Rank
PE 15.72
Fwd PE 8.19
ECN.CA Price Earnings VS Forward Price EarningsECN.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

100.00% of the companies in the same industry are more expensive than ECN, based on the Enterprise Value to EBITDA ratio.
ECN's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ECN is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 3.25
EV/EBITDA 11.53
ECN.CA Per share dataECN.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

ECN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ECN's earnings are expected to grow with 42.84% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.16
PEG (5Y)N/A
EPS Next 2Y65.25%
EPS Next 3Y42.84%

3

5. Dividend

5.1 Amount

ECN has a Yearly Dividend Yield of 1.38%.
ECN's Dividend Yield is a higher than the industry average which is at 7.86.
Compared to an average S&P500 Dividend Yield of 2.38, ECN's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.38%

5.2 History

The dividend of ECN decreases each year by -5.51%.
ECN has been paying a dividend for at least 10 years, so it has a reliable track record.
ECN has decreased its dividend in the last 3 years.
Dividend Growth(5Y)-5.51%
Div Incr Years0
Div Non Decr Years2
ECN.CA Yearly Dividends per shareECN.CA Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6

5.3 Sustainability

ECN pays out 22763.77% of its income as dividend. This is not a sustainable payout ratio.
DP22763.77%
EPS Next 2Y65.25%
EPS Next 3Y42.84%
ECN.CA Yearly Income VS Free CF VS DividendECN.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B
ECN.CA Dividend Payout.ECN.CA Dividend Payout, showing the Payout Ratio.ECN.CA Dividend Payout.PayoutRetained Earnings

ECN CAPITAL CORP

TSX:ECN (10/17/2025, 7:00:00 PM)

2.83

-0.06 (-2.08%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)11-05 2025-11-05
Inst Owners47.31%
Inst Owner ChangeN/A
Ins Owners6.76%
Ins Owner ChangeN/A
Market Cap796.59M
Analysts75
Price Target3.76 (32.86%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.38%
Yearly Dividend0.08
Dividend Growth(5Y)-5.51%
DP22763.77%
Div Incr Years0
Div Non Decr Years2
Ex-Date09-12 2025-09-12 (0.01)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-8.07%
Min EPS beat(2)-15.14%
Max EPS beat(2)-0.99%
EPS beat(4)0
Avg EPS beat(4)-22.53%
Min EPS beat(4)-64%
Max EPS beat(4)-0.99%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)1.47%
Min Revenue beat(2)-7.2%
Max Revenue beat(2)10.15%
Revenue beat(4)2
Avg Revenue beat(4)1.46%
Min Revenue beat(4)-7.75%
Max Revenue beat(4)10.65%
Revenue beat(8)4
Avg Revenue beat(8)1.69%
Revenue beat(12)4
Avg Revenue beat(12)-4.29%
Revenue beat(16)4
Avg Revenue beat(16)-13.52%
PT rev (1m)0%
PT rev (3m)-3.28%
EPS NQ rev (1m)0%
EPS NQ rev (3m)5.55%
EPS NY rev (1m)-1.39%
EPS NY rev (3m)-8.51%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.41%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.23%
Valuation
Industry RankSector Rank
PE 15.72
Fwd PE 8.19
P/S 2.38
P/FCF 3.25
P/OCF 3.24
P/B 2.83
P/tB N/A
EV/EBITDA 11.53
EPS(TTM)0.18
EY6.36%
EPS(NY)0.35
Fwd EY12.2%
FCF(TTM)0.87
FCFY30.76%
OCF(TTM)0.87
OCFY30.87%
SpS1.19
BVpS1
TBVpS-0.29
PEG (NY)0.16
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.01%
ROE 0.03%
ROCE 9.08%
ROIC 4.31%
ROICexc 4.38%
ROICexgc 6.89%
OM 33.3%
PM (TTM) 0.03%
GM N/A
FCFM 73.1%
ROA(3y)-2.68%
ROA(5y)14.79%
ROE(3y)-16.1%
ROE(5y)77.16%
ROIC(3y)2.48%
ROIC(5y)1.63%
ROICexc(3y)2.52%
ROICexc(5y)1.66%
ROICexgc(3y)3.6%
ROICexgc(5y)2.66%
ROCE(3y)5.23%
ROCE(5y)3.43%
ROICexcg growth 3Y47.97%
ROICexcg growth 5Y17.4%
ROICexc growth 3Y100.79%
ROICexc growth 5Y25.74%
OM growth 3Y87.71%
OM growth 5Y15.55%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.25
Health
Industry RankSector Rank
Debt/Equity 2.85
Debt/FCF 3.27
Debt/EBITDA 5.79
Cap/Depr 3.52%
Cap/Sales 0.28%
Interest Coverage 1.7
Cash Conversion 177.56%
Profit Quality 252664%
Current Ratio 1.05
Quick Ratio 1.05
Altman-Z 0.05
F-Score7
WACC5.92%
ROIC/WACC0.73
Cap/Depr(3y)114.58%
Cap/Depr(5y)86.26%
Cap/Sales(3y)8.73%
Cap/Sales(5y)6.74%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)750%
EPS 3Y-34.48%
EPS 5Y-20.31%
EPS Q2Q%33.33%
EPS Next Y99.19%
EPS Next 2Y65.25%
EPS Next 3Y42.84%
EPS Next 5YN/A
Revenue 1Y (TTM)33.31%
Revenue growth 3Y21.98%
Revenue growth 5Y-1.56%
Sales Q2Q%3.83%
Revenue Next Year11.92%
Revenue Next 2Y14.36%
Revenue Next 3Y12.04%
Revenue Next 5YN/A
EBIT growth 1Y178.05%
EBIT growth 3Y128.98%
EBIT growth 5Y13.75%
EBIT Next Year99.8%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y153.35%
FCF growth 3Y11.95%
FCF growth 5Y-6.78%
OCF growth 1Y156.44%
OCF growth 3Y10.19%
OCF growth 5Y-7.11%